SFN reduces HDAC1, 4, 5, and 7 protein levels in cancer cells [173] and inhibits class I HDACs, such as HDAC2, as well as class IIa HDACs, such as HDAC4, 5, 7, and 9, in 3T3-L1 adipocytes [174]. Here, HDAC2 is linked to cancer.